Implications of maturation for viral gene delivery to skeletal muscle.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuromuscular Disorders

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0960-8966(98)00019-4PMID 9631393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles

  1998cited by this paper
• Floyd, S.S. Jr. et al. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther. 5, 19-30

  1998cited by this paper
• Clinical neurophysiology: by Jasper R. Daube, 1996, 533 pp. A Davis Company, Philadelphia, ISBN 0-8036-0073-9, £135.00

  1997cited by this paper
• The fate of individual myoblasts after transplantation into muscles of DMD patients

  1997cited by this paper
• Viral Gene Delivery to Skeletal Muscle: Insights on Maturation-Dependent Loss of Fiber Infectivity for Adenovirus and Herpes Simplex Type 1 Viral Vectors

  1997cited by this paper
• LacZ Gene Transfer to Skeletal Muscle Using a Replication-Defective Herpes Simplex Virus Type 1 Mutant Vector

  1997cited by this paper
• Gene transfer to muscle using herpes simplex virus-based vectors.

  1997cited by this paper
• Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle

  1997cited by this paper
• Myoblast-Mediated Ex Vivo Gene Transfer to Mature Muscle

  1997cited by this paper
• Dystrophin Expression in Muscles of mdx Mice After Adenovirus-Mediated In Vivo Gene Transfer

  1996cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Construction of Human Factor IX Expression Vectors in Retroviral Vector Frames Optimized for Muscle Cells

  1996cited by this paper
• In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes

  1996cited by this paper
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

  1996cited by this paper
• Prevention of Immune Reactions Triggered by First-Generation Adenoviral Vectors by Monoclonal Antibodies and CTLA4Ig

  1996cited by this paper
• Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

  1996cited by this paper
• Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

  1996cited by this paper
• Rapid death of injected myoblasts in myoblast transfer therapy

  1996cited by this paper
• In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

  1996cited by this paper
• The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers

  1996cited by this paper
• Replication-defective herpes simplex virus vectors for gene transfer in vivo.

  1996cited by this paper
• Impairment of Force Generation after Adenovirus-Mediated Gene Transfer to Muscle Is Alleviated by Adenoviral Gene Inactivation and Host CD8+ T Cell Deficiency

  1996cited by this paper
• Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs.

  1995cited by this paper
• Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.

  1995cited by this paper
• Intramuscular Delivery of Rat Kallikrein-binding Protein Gene Reverses Hypotension in Transgenic Mice Expressing Human Tissue Kallikrein (*)

  1995cited by this paper
• Herpes simplex virus type 1 vector mediated gene transfer to muscle.

  1995cited by this paper
• FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene Transfer

  1995cited by this paper
• Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung

  1995cited by this paper
• Successful myoblast allotransplantation in mdx mice using rapamycin.

  1995cited by this paper
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats.

  1995cited by this paper
• Culturing satellite cells from living single muscle fiber explants

  1995cited by this paper
• Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants.

  1995cited by this paper
• Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice.

  1995cited by this paper
• Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

  1995cited by this paper
• Retroviral-mediated in vivo gene transfer into muscle cells and synthesis of human factor IX in mice.

  1995cited by this paper
• Rapid death of donor myoblasts after intramuscular injection in myoblast transfer therapy

  1995cited by this paper
• Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

  1994cited by this paper
• Gene Transfer in Regenerating Muscle

  1994cited by this paper
• Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function

  1994cited by this paper
• Gene Transfer into Skeletal Muscles by Isogenic Myoblasts

  1994cited by this paper
• A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity.

  1994cited by this paper
• Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines.

  1994cited by this paper
• Persistent Erythropoiesis by Myoblast Transfer of Erythropoietin cDNA

  1994cited by this paper
• Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.

  1994cited by this paper
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

  1994cited by this paper
• Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants.

  1994cited by this paper
• Pharmacological enhancement of in vivo foreign gene expression in muscle.

  1994cited by this paper
• Retroviral Vector-Mediated Gene Transfer into Human Primary Myogenic Cells Leads to Expression in Muscle Fibers In Vivo

  1993cited by this paper
• Myoblast transfer in duchenne muscular dystrophy

  1993cited by this paper
• Invited Review. The potential for gene therapy in duchenne muscular dystrophy and other genetic muscle diseases

  1993cited by this paper
• Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy

  1993cited by this paper
• Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene

  1993cited by this paper
• Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo.

  1993cited by this paper
• Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

  1993cited by this paper
• Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle

  1993cited by this paper
• Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

  1993cited by this paper
• Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo.

  1993cited by this paper
• Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.

  1992cited by this paper
• Retroviral‐mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro

  1992cited by this paper
• Expression of human factor IX in mice after injection of genetically modified myoblasts.

  1992cited by this paper
• Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

  1992cited by this paper
• Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

  1992cited by this paper
• Human myoblast transplantation: Preliminary results of 4 cases

  1992cited by this paper
• Adenovirus as an expression vector in muscle cells in vivo.

  1992cited by this paper
• Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.

  1992cited by this paper
• Systemic delivery of recombinant proteins by genetically modified myoblasts.

  1991cited by this paper
• Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

  1991cited by this paper
• Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

  1991cited by this paper
• Retroviral-mediated gene transfer into hepatocytes in vivo.

  1991cited by this paper
• Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

  1990cited by this paper
• Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse

  1990cited by this paper
• Assembly of Basement Membranes a

  1990cited by this paper
• Stable incorporation of a bacterial gene into adult rat skeletal muscle in vivo.

  1990cited by this paper
• The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.

  1989cited by this paper
• Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

  1989cited by this paper
• Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat.

  1989cited by this paper
• Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation.

  1989cited by this paper
• Regeneration of muscles after cardiotoxin injury I. Cytological aspects

  1988cited by this paper
• Immunoelectron microscopic localization of dystrophin in myofibres

  1988cited by this paper
• Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

  1987cited by this paper
• The replication of herpes viruses.

  1974cited by this paper
• The icosahedral form of an adenovirus

  1959cited by this paper

• Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectors

  2025cites this paper
• Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature

  2019cites this paper
• 3-1-2018 EPC / HPSG evidence-based guidelines for the management of pediatric pancreatitis

  2018cites this paper
• EPC/HPSG evidence-based guidelines for the management of pediatric pancreatitis.

  2018cites this paper
• Identification of Herpes Zoster–Associated Temporal Arteritis Among Cases of Giant Cell Arteritis

  2017cites this paper
• The Combined Use of Losartan and Muscle-Derived Stem Cells Significantly Improves the Functional Recovery of Muscle in a Young Mouse Model of Contusion Injuries

  2016cites this paper
• Gene Delivery Systems

  2013cites this paper
• The Microenvironment-Specific Transformation of Adult Stem Cells Models Malignant Triton Tumors

  2013cites this paper
• Role of angiogenesis after muscle derived stem cell transplantation in injured medial collateral ligament

  2012cites this paper
• Intramuscular Transplantation of Muscle-Derived Stem Cells Accelerates Skeletal Muscle Healing After Contusion Injury via Enhancement of Angiogenesis

  2011cites this paper
• Gene Therapy and Tissue Engineering in Orthopaedic and Sports Medicine

  2011cites this paper
• Peripheral Nerve Tissue Engineering: Strategies for Repair and Regeneration

  2011cites this paper
• Promoters influence the kinetics of transgene expression following adenovector gene delivery

  2008cites this paper
• Gene Therapy and Tissue Engineering Based on Muscle-Derived Stem Cells: Potential for Musculoskeletal Tissue Regeneration and Repair

  2007cites this paper
• Antioxidant (Oxiprovin TM) supplementation and muscle recovery from contusion injury - an in vivo study

  2007cites this paper
• 486. Efficient and Selective Gene Transfer Directed to Muscle by Tropism-Modified Adeno-Associated Virus Vector

  2006cites this paper
• Cell therapy for muscle regeneration and repair.

  2005cites this paper
• Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells

  2005cites this paper
• Management of Skeletal Muscle Injuries in Military Personnel

  2005cites this paper
• DEVELOPING TISSUE ENGINEERING AND GENE THERAPY APPROACHES INVOLVING THE USE OF NERVE GROWTH FACTOR AND MUSCLE-DERIVED STEM CELLS TO IMPROVE THE REGENERATION OF DYSTROPHIC MUSCLE

  2005cites this paper
• Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD)

  2004cites this paper
• Adenovirus vectors targeting αV integrin or heparan sulfate receptors display different distribution of transgene activity after intramuscular injection

  2004cites this paper
• Gene transfer to skeletal muscle using herpes simplex virus-based vectors.

  2004cites this paper
• Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells

  2004cites this paper
• Adenovirus-mediated gene delivery to skeletal muscle.

  2004cites this paper
• Tetracycline-regulated secretion of human insulin in a transfected non-endocrine cell line.

  2003cites this paper
• Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors.

  2003cites this paper
• Myotoxic phospholipases A2 and the regeneration of skeletal muscles.

  2003cites this paper
• Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene

  2003cites this paper
• Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

  2002cites this paper
• High-efficiency adenovirus-mediated in vivo gene transfer into neonatal and adult rodent skeletal muscle.

  2002cites this paper
• High efficiency transfection of primary skeletal muscle cells with lipid‐based reagents

  2002cites this paper
• Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle

  2002cites this paper
• Muscle injuries and repair: current trends in research.

  2002cites this paper
• Adenovirus mediated gene transfer to skeletal muscle

  2002influential citation
• Gene Delivery Using Herpes Simplex Virus Vectors

  2002cites this paper
• Gene therapy in orthopaedic surgery.

  2002cites this paper
• Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig- Maximilians-Universität München Gene transfer to skeletal muscle using adenoviral recombinants

  2002cites this paper
• Transduction and Apoptosis Induction in the Rat Prostate, Using Adenovirus Vectors

  2001cites this paper
• Muscle-based gene therapy and tissue engineering.

  2001cites this paper
• Multiple Applications For Replication‐Defective Herpes Simplex Virus Vectors

  2001cites this paper
• Muscle-based gene therapy and tissue engineering for the musculoskeletal system.

  2001cites this paper
• Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.

  2001cites this paper
• The development of herpes simplex virus vectors for cancer and gene therapy

  2001cites this paper
• Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence.

  2001cites this paper
• Autologous Primary Muscle-Derived Cells Transfer into the Lower Urinary Tract

  2001cites this paper
• The role of receptors in the maturation-dependent adenoviral transduction of myofibers

  2001cites this paper
• Novel therapies for muscular dystrophy and other muscle wasting conditions

  2001cites this paper
• Muscle-Specific Overexpression of the Adenovirus Primary Receptor CAR Overcomes Low Efficiency of Gene Transfer to Mature Skeletal Muscle

  2001cites this paper
• The Use of Different Vectors and Strategies for Gene Transfer to the Musculoskeletal System

  2000cites this paper
• Animal models for muscular dystrophy: valuable tools for the development of therapies.

  2000cites this paper
• Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy

  2000cites this paper
• HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes.

  2000cites this paper
• The Use of Adeno-Associated Virus to Circumvent the Maturation-Dependent Viral Transduction of Muscle Fibers

  2000influential citation
• The Influence of Muscle Fiber Type in Myoblast-Mediated Gene Transfer to Skeletal Muscles

  2000cites this paper
• Adeno—Associated Virus (AAV) Vectors for Musculoskeletal Gene Transfer

  2000cites this paper
• Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone.

  1999cites this paper
• Is there a future for gene therapy?

  1999cites this paper
• Extended tropism of an adenoviral vector does not circumvent the maturation‐dependent transducibility of mouse skeletal muscle

  1999cites this paper
• Thérapie génique des dystrophies musculaires

  1999cites this paper
• Efficient infection of mature skeletal muscle with herpes simplex virus vectors by using dextran sulfate as a co-receptor

  1999cites this paper
• Muscle-based tissue engineering for the musculoskeletal system

  1999cites this paper
• Herpes simplex virus vector‐mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle

  1999cites this paper
• Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy

  1998influential citation
• Development of approaches to improve the healing following muscle contusion.

  1998cites this paper
• Development of Approaches to Improve the Healing following Muscle Contusion

  1998cites this paper